Capstone Investment Advisors, LLC Nektar Therapeutics Put Options Transaction History

Capstone Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $30,348 - $42,192	-1,800 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $505,003 - $975,804	-34,900 Reduced 95.1%	1,800 $32,000
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $44,436 - $64,736	2,800 Added 8.26%	36,700 $792,000
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $52,421 - $112,437	3,100 Added 10.06%	33,900 $617,000
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $58,900 - $68,970	1,900 Added 6.57%	30,800 $1.1 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $227,376 - $333,720	7,200 Added 33.18%	28,900 $971,000
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $118,677 - $220,935	3,900 Added 21.91%	21,700 $713,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $826,988 - $1.22 Million	17,800 New	17,800 $1.09 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.